Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Apply
Autologous T Cells
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step